美味健康饮食降低克罗恩病高危一级亲属粪便钙卫蛋白:PIONIR随机交叉试验
BACKGROUND: With the rising prevalence of inflammatory bowel disease (IBD), preventing new-onset disease becomes a priority.…
要点
- Tasty&Healthy饮食8周可降低高危一级亲属粪便钙卫蛋白,且耐受性和依从性良好。
- 第8周Tasty&Healthy饮食组粪便钙卫蛋白≥50%下降比例达71%,习惯饮食组为27%。
- 交叉分析中Tasty&Healthy饮食使粪便钙卫蛋白估计边际均值下降61%,支持长期饮食预防试验。
核心结论
- 在无克罗恩病诊断性内镜证据但粪便钙卫蛋白持续升高的健康高危一级亲属中,低度肠道炎症具有可修饰性。
主要发现
- 交叉分析中Tasty&Healthy饮食使估计边际均值粪便钙卫蛋白从185μg/g(95%CI 144-237)下降61%至72μg/g(95%CI 57-91),习惯饮食下降38%至114μg/g(95%CI 93-140),比值0.63(95%CI 0.51-0.80),总体下降37%(P<0.001)。
- FDR校正后6种微生物物种在两种饮食间存在差异。
- 第8周79%认为Tasty&Healthy饮食可接受,83%依从性良好或完全依从。
临床怎么用
- 对克罗恩病高危一级亲属中粪便钙卫蛋白持续升高但内镜无诊断性病变者,可考虑Tasty&Healthy饮食干预以降低肠道炎症标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With the rising prevalence of inflammatory bowel disease (IBD), preventing new-onset disease becomes a priority. The PIONIR (Preventing IBD ONset in Individuals at Risk) randomized controlled trial explored whether the Tasty&Healthy (T&H) diet reduces inflammatory markers in high-risk first-degree relatives (FDRs) of patients with Crohn's disease (CD). METHODS: FDRs with persistently elevated fecal calprotectin (FC, >70μg/g) and, at most, nonspecific mucosal abnormalities (edema or ≤10 aphthous ulcers) on video-capsule endoscopy or ileocolonoscopy were randomized to T&H or habitual diet (HD) for 8 weeks, followed by crossover for additional 8 weeks. Treatment effect on the primary outcome, FC response, was analyzed using generalized estimating equations for the two-period, two-sequence crossover design, following the intention-to-treat principle. RESULTS: Twenty-nine FDRs were randomized (n=14 T&H-first, n=15 HD-first). At week 8, median FC was lower with T&H (64μg/g [IQR 44-127]) vs. HD (112μg/g [74-227]; P=.022). FC decreased by ≥50% in 71% on T&H versus 27% on HD (RR=2.68 [95%CI 1.09-6.60]; P=.016). Across both crossover periods, estimated marginal mean FC declined from 185μg/g [95%CI 144-237] by 61% to 72μg/g [95%CI 57-91] with T&H, versus 38% to 114μg/g [95%CI 93-140] with HD (ratio 0.63 [95%CI 0.51-0.80], translating to 37% overall decrease with T&H; P<0.001). Six microbial species differed between diets after FDR correction. By week 8, 79% rated T&H acceptable and 83% had good or complete adherence. CONCLUSION: These findings demonstrate the modifiability of low-grade intestinal inflammation in healthy high-risk FDRs with persistent FC elevation but without diagnostic endoscopic evidence of CD, supporting long-term dietary prevention trials (ClinicalTrials.gov #NCT05211518).
引用
- Turner D, Kenigsberg S, Plotkin L, et al. TASTY AND HEALTHY DIET REDUCES FECAL CALPROTECTIN IN HIGH-RISK FIRST-DEGREE RELATIVES OF PATIENTS WITH CROHN'S DISEASE: PIONIR RANDOMIZED CROSSOVER TRIAL. Gastroenterology. 2026. PMID: 42933673. doi:10.1053/j.gastro.2026.10.376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。